Trial Profile
Platelet reactivity after TAVI: A multicenter randomized clinical trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Nov 2017
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin/clopidogrel
- Indications Aortic disorders
- Focus Therapeutic Use
- Acronyms REAC-TAVI
- 29 Nov 2017 Status changed from recruiting to completed.
- 07 Jul 2015 New trial record